Efficacy and safety of fosravuconazole L ‐lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double‐blind, randomized phase III study

The Journal of Dermatology, EarlyView.

Source: The Journal of Dermatology - August 29, 2018 Category: Dermatology Authors: Shinichi Watanabe , Ichiro Tsubouchi , Akihiro Okubo Source Type: research